- Citations, last 5 years
- 119
- Works, last 5 years
- 8
- h-index
- 23
- Scientists listed
- 0
- Grants since 2016
- 11
Grants received
2021–2024 · research · R44
Immune cell targeting of corticosteroids transforms the treatment of severe, chronic inflammatory diseases
Jay L Rothstein · ImmuNext (United States) · funded by National Institutes of Health
2021–2024 · research · R44
Immune cell targeting of corticosteroids transforms the treatment of severe, chronic inflammatory diseases
Jay L Rothstein · ImmuNext (United States) · funded by National Institutes of Health
2021–2023 · research · R44
Immune cell targeting of corticosteroids transforms the treatment of severe, chronic inflammatory diseases
Jay L Rothstein · ImmuNext (United States) · funded by National Institutes of Health
2018–2022 · research · R44
Targeting leukocyte metabolism to treat human autoimmune disease
Jay L Rothstein · ImmuNext (United States) · funded by National Institutes of Health
2018–2021 · research · R44
Targeting leukocyte metabolism to treat human autoimmune disease
Jay L Rothstein · ImmuNext (United States) · funded by National Institutes of Health
2018–2021 · research · R44
Targeting leukocyte metabolism to treat human autoimmune disease
Jay L Rothstein · ImmuNext (United States) · funded by National Institutes of Health
2018 · research · R44
Targeting leukocyte metabolism to treat human autoimmune disease
Jay L Rothstein · ImmuNext (United States) · funded by National Institutes of Health
2017 · research · R44
Targeting the checkpoint regulator VISTA for treatment of inflammatory disease
Jay L Rothstein · ImmuNext (United States) · funded by National Institutes of Health
2017–2020 · research · R44
Targeting the checkpoint regulator VISTA for treatment of inflammatory disease
Jay L Rothstein · ImmuNext (United States) · funded by National Institutes of Health
2017–2020 · research · R44
Targeting the checkpoint regulator VISTA for treatment of inflammatory disease
Jay L Rothstein · ImmuNext (United States) · funded by National Institutes of Health
2017–2020 · research · R44
Targeting the checkpoint regulator VISTA for treatment of inflammatory disease
Jay L Rothstein · ImmuNext (United States) · funded by National Institutes of Health